NEW YORK (Reuters Health) – Breast cancer recurrence rates are lower with aromatase inhibitors than with tamoxifen, according to meta-analyses published online by the Journal of Clinical Oncology.…
NEW YORK (Reuters Health) – High-flow inhaled oxygen is an effective treatment for cluster headache attacks, investigators said in the Journal of the American Medical Association for December…
NEW YORK (Reuters Health) – Children who are disease-free 5 years after a cancer diagnosis are still at risk for recurrence for another 20 years or more, new…
NEW YORK (Reuters Health) – Abatacept, an agent that modifies the costimulatory signal required for T-cell activation, does not increase malignancy rates in patients with rheumatoid arthritis (RA),…
NEW YORK (Reuters Health) – Methadone is a safe, effective first- or second-line treatment of cancer pain, even in outpatients, a retrospective study suggests. Concerns over its long…
NEW YORK (Reuters Health) – For men with hot flushes from androgen suppression for prostate cancer, medroxyprogesterone appears to be the best option for relief, according to a…
A new study suggests that patient safety experts should focus as much of their attention on human factors as system factors if they want to reduce avoidable medical…
NEW YORK (Reuters Health) – Recombinant human erythropoietin (EPO) provides no benefit after acute ischemic stroke, and may even be dangerous, particularly in patients receiving systemic thrombolysis. These…
NEW YORK (Reuters Health) – New research suggests that high-dose vitamin D can be safely given to breast cancer patients with bone metastases, but it will not affect…
NEW YORK (Reuters Health) – New research shows that antidiabetes agents are not equal when it comes to cardiovascular risks and mortality. According to a report in the…
NEW YORK (Reuters Health) – Elevated C-reactive protein (CRP) levels are linked with an increased risk of stent thrombosis and cardiovascular events in patients with drug-eluting stents, say…
NEW YORK (Reuters Health) – Ultrasound is a reliable means of screening for tethered cord syndrome in infants with dorsal midline skin stigmata, new research shows. However, such…
